Human Medicines European Public Assessment Report (EPAR): Aclasta, Zoledronic Acid, Osteoporosis,Osteitis Deformans,Osteoporosis, Postmenopausal, Date of Authorisation: 15/04/2005, Revision: 25, Status: Authorised

Case Medical Research

doi 10.31525/cmr-6ac6f4